SLC5A2 and type 2 diabetes mellitus: SGLT2 inhibitors, including canagliflozin, dapagliflozin, empagliflozin, and so on, have proven efficacy when used to treat type 2 diabetes, and all of them were considered effective in reducing body weight (10).